发明名称 |
Pharmaceutical Compositions for Angiogenic Therapy |
摘要 |
The present invention provides: (1) pharmaceutical compositions for angiogenic therapy which contain, as the active ingredients, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect, and substances producing them; and a gene encoding an angiogenesis factor; (2) agents for potentiating the angiogenic effect of a gene encoding an angiogenesis factor that contain, as the active ingredient, at least one substance selected from substances having vasodilating effect and/or platelet aggregation inhibitory effect and substances producing them; (3) an angiogenic agent which contains a prostacyclin synthase gene as the active ingredient; (4) pharmaceutical compositions for angiogenic therapy which contain ets-1 gene and another gene encoding an angiogenesis factor as the active ingredients; (4) an agent which contain ets 1 gene as the active ingredient for potentiating the angiogenic effect of another gene encoding an angiogenesis factor; and (5) an angiogenic agent which contains ets-1 gene as the active ingredient. |
申请公布号 |
US2010240735(A1) |
申请公布日期 |
2010.09.23 |
申请号 |
US20090435335 |
申请日期 |
2009.05.04 |
申请人 |
ANGES MG, INC. (FORMERLY MEDGENE BIOSCIENCE, INC.) |
发明人 |
MORISHITA RYUICHI;KOIKE HIROMI;TANABE TADASHI;AOKI MOTOKUNI |
分类号 |
A61K31/7088;A61K31/5585;A61K31/711;A61K38/17;A61K38/52;A61K48/00;A61P9/00;A61P9/10 |
主分类号 |
A61K31/7088 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|